Detail Information of Transcriptional Regulations
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0095 Transporter Info | ||||
| Gene Name | SLC13A5 | ||||
| Transporter Name | Sodium-coupled citrate transporter | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Transcriptional Regulation of This DT (TSR) | ||||||
|---|---|---|---|---|---|---|
|
Class 1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
CREB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC13A5 gene | [1] | ||||
|
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
|
Tissue |
Liver | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC13A5 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled citrate transporter. | |||||
|
Class 1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
|
AHR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Activation of SLC13A5 gene in health condition | [2] | ||||
|
TF Protein Name |
Aryl hydrocarbon receptor | Transcription Factor Info | ||||
|
Affected Drug/Substrate |
Citrate | |||||
|
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
|
Tissue |
Liver | |||||
|
Related DT Changes |
Up regulating | |||||
|
Experimental Material |
Wistar rats | |||||
|
Detailed Description |
Aryl hydrocarbon receptor (AHR) has been reported to activate the transcription of SLC13A5 gene in health condition, which leads to an increased expression of the drug transporter Sodium-coupled citrate transporter. | |||||
|
TCF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC13A5 gene | [3] | ||||
|
TF Protein Name |
Transcription factor E2-alpha | Transcription Factor Info | ||||
|
Tissue |
Blood | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Transcription factor E2-alpha (TCF3) can directly bind to the SLC13A5 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled citrate transporter. | |||||
|
Class 2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
NR1I2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Activation of SLC13A5 gene in health condition | [4] | ||||
|
TF Protein Name |
Nuclear receptor subfamily 1 group I member 2 | Transcription Factor Info | ||||
|
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
|
Tissue |
Liver | |||||
|
Related DT Changes |
Up regulating | |||||
|
Experimental Material |
human primary hepatocyte isolates | |||||
|
Detailed Description |
Nuclear receptor subfamily 1 group I member 2 (NR1I2) has been reported to activate the transcription of SLC13A5 gene in health condition, which leads to an increased expression of the drug transporter Sodium-coupled citrate transporter. | |||||
|
Class 2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC13A5 gene | [3] | ||||
|
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
|
Tissue |
Liver; Lung | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SLC13A5 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled citrate transporter. | |||||
|
Class 3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
E2F6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC13A5 gene | [5] | ||||
|
TF Protein Name |
Transcription factor E2F6 | Transcription Factor Info | ||||
|
Tissue |
Bone marrow; Embryo; Lung | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Transcription factor E2F6 (E2F6) can directly bind to the SLC13A5 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled citrate transporter. | |||||
|
Class 3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
|
GABPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC13A5 gene | [6] | ||||
|
TF Protein Name |
GA-binding protein alpha chain | Transcription Factor Info | ||||
|
Tissue |
Embryo; Liver; Lung | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
GA-binding protein alpha chain (GABPA) can directly bind to the SLC13A5 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled citrate transporter. | |||||
|
SPI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC13A5 gene | [1] | ||||
|
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
|
Tissue |
Adrenal gland; Blood; Brain; Breast; Embryo; Foreskin; Heart; Intestine; Kidney; Lung; Muscle; Penis; Renal cortex; Renal pelvis; Skin; Spinal cord; Stomach; Testes; Umbilical cord blood | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Transcription factor PU.1 (SPI1) can directly bind to the SLC13A5 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled citrate transporter. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.